Tag: Pediatric Health
-
Now is the Time to Protect Babies from RSV: Practical Steps for Parents
RSV: Why This Season Demands Extra Vigilance for Babies Respiratory syncytial virus (RSV) is a common winter illness that can affect people of all ages, but infants—especially newborns and those with underlying health issues—are at higher risk for severe disease. Pediatricians, including Kristin Barrett of Cleveland Clinic Children’s, stress that protecting infants from RSV isn’t…
-
Now Is the Time to Protect Babies From RSV: Practical Guidance for Parents
RSV: A Common Threat to Baby Health Respiratory syncytial virus (RSV) is a pervasive infection in communities, especially common in fall and winter. While many healthy adults recover quickly, RSV can be serious for babies, particularly those born prematurely or with underlying health issues. Pediatric experts, including Kristin Barrett from Cleveland Clinic Children’s, emphasize that…
-
Protect Babies from RSV: Essential Prevention Tips
Why RSV Matters for Babies RSV, or respiratory syncytial virus, is a common respiratory infection that can be especially serious for infants. Pediatric experts note that while RSV is widespread in communities, certain babies are more vulnerable to severe illness. Dr. Kristin Barrett, a pediatrician at Cleveland Clinic Children’s, emphasizes the importance of protecting newborns…
-
Migraine Linked to Hypertension in Adolescents: New Findings
Introduction New research published in Hypertension adds to growing evidence that migraine and hypertension are linked in adolescents, especially among those with severe migraine. While the two conditions have historically been studied separately in young people, the latest findings suggest that teens with frequent or disabling migraines may have an increased risk of elevated blood…
-
HSE urges parents of newborns to vaccinate against RSV
RSV Vaccination Guidance from the HSE The Health Service Executive (HSE) is urging parents of newborns to consider RSV vaccination for their babies. The push targets infants born between 1 March and 31 August 2025 who did not take up the September vaccination window. Health officials say protecting infants early can help reduce the impact…
-
HSE Urges Parents to Vaccinate Newborns Against RSV Without Delay
New Guidance from the HSE on RSV Vaccination The Health Service Executive (HSE) has issued a strong reminder to parents of babies born between 1 March and 31 August 2025. If your newborn did not receive the RSV vaccination during the September window, it is advised to book as soon as possible to ensure protection…
-
Diabetes in Kids: How Early Eating Habits Shape Lifelong Health
Why early eating habits matter for a child’s health Doctors and nutrition experts stress that the first decade of life is a window of opportunity. The foods children eat, how often they eat, and the routines around meals can influence body weight, energy balance, and the body’s ability to regulate blood sugar. Establishing healthy eating…
-
Monoclonal Antibodies Shield Infants from RSV: A New Era of Protection
Understanding RSV and the Vulnerable Population Respiratory syncytial virus (RSV) is a common winter respiratory infection that typically presents as a cold-like illness in healthy individuals. Yet, for young infants—especially those under six months—the elderly, and children with certain health conditions, RSV can lead to serious complications requiring hospitalization. In recent years, scientists and clinicians…
-
Pediatrician Dr. Shafqat Bhurguri Calls for Vaccination Against Measles and Rubella
A Trusted Call to Action from a Renowned Pediatrician In a key public health message, Dr. Shafqat Bhurguri, a respected pediatrician, is urging parents to ensure their children receive the measles and rubella (MR) vaccine. He emphasizes that the MR vaccine is not only safe and effective but also essential in shielding children from two…
-
Monoclonal Antibody Protects Children from RSV: Real-World Evidence
Groundbreaking real-world evidence supports nirsevimab’s role against RSV In a significant step forward for pediatric infectious disease prevention, a large real-world study published in the Journal of Infection provides fresh evidence that the long-acting monoclonal antibody nirsevimab (Beyfortus) offers protection against respiratory syncytial virus (RSV) infection in children. The findings, drawn from diverse clinical settings,…